基于Web of Science的托法替布文献计量学分析  

Bibliometrics analysis of tofacitinib based on Web of Science

作　　者：孙志勇[1] 史香芬[1] 卢晓静 张晓坚[1] SUN Zhiyong;SHI Xiangfen;LU Xiaojing;ZHANG Xiaojian(Department of Pharmacy,The First Affiliated Hospital of Zhengzhou University,Henan Zhengzhou 450052,China)

机构地区：[1]郑州大学第一附属医院药学部,河南郑州450052

出　　处：《中国医院药学杂志》2023年第13期1499-1505,共7页Chinese Journal of Hospital Pharmacy

基　　金：河南省医学科技攻关计划软科学项目(编号:RKX202202027)。

摘　　要：目的:基于文献计量学分析托法替布相关研究现状和热点。方法:计算机检索Web of Science(WOS)核心合集数据库发表的托法替布相关研究文献,检索时间为建库至2022年9月17日。利用VOSviewer(1.6.17)统计分析相关研究的国家/地区、机构、作者、期刊分布等文献关键特征并制作可视化图谱,运用CiteSpace(5.8.R3)分析该研究领域的研究热点。结果:建库至2022年9月17日,Web of Science共收录托法替布相关论文2 164篇。77个国家/地区发表相关研究,其中,发文量最多的国家是美国;发文量最多的机构为美国辉瑞公司;发文量最多的作者来自以Yoshiya Tanaka为核心的研究团队;被引频次排名第一的高被引作者是辉瑞公司的Samuel H Zwillich;杂志Annals of the Rheumatic Diseases是发文量和被引频次均最高的杂志;本领域的研究热点是托法替布长期安全性、疗效的评估、基于循证医学证据更新相关疾病管理建议、用于其他未批准自身免疫疾病的临床探索、不良反应危险因子分析。结论:随着托法替布临床的广泛应用,通过文献计量学分析有助于研究人员了解该领域的研究趋势和热点话题。OBJECTIVE To explore the current status and hotpots of the research of tofacitinib based on bibliometric analysis.METHODS Relevant research literature of tofacitinib was searched from the Web of Science Core Collection(WOSCC),and the retrieval time was from the establishment of the database to September 17,2022.Software VOSviewer(1.6.17) was applied to statistical analysis and visualization of the key characteristics of relevant studies,such as countries/regions,institutions,authors and journals;CiteSpace(5.8.R3) was used to analyze the research hotpots.RESULTS From the establishment of the database to September 17,2022,Web of Science covered a total of 2164 publications on tofacitinib.Totally 77 countries/regions published related research,of which the United States ranked first in number of publication;the Pfizer Inc.in the United States issued the most publications;the most studies were devoted by the research team led by Yoshiya Tanaka,and the highest co-citation author was Samuel H Zwillich,a scholar from Pfizer Inc.;annals of the Rheumatic Diseases ranked first not only in the top productive,but also the co-cited journals.The hotpots included long-term safety/efficacy evaluation of tofacitinib,evidence-based guideline update,clinical exploration for other unapproved diseases,and adverse reaction risk factor analysis.CONCLUSION With the wide clinical application of tofacitinib,the bibliometrics analysis helps researchers get insights of the research trends and hotpots in this field.

关 键 词：托法替布 文献计量学 VOSviewer CITESPACE 

分 类 号：R977[医药卫生—药品] G353.1[医药卫生—药学]